ChainCatcher news, AminoChain announced the completion of a $5 million seed round financing, led by a16z, marking a16z's first investment in a decentralized science (DeSci) project.It is reported that AminoChain is building an L2 blockchain protocol that connects enterprise healthcare institutions and developing user-owned decentralized healthcare applications on this protocol. The first application built on AminoChain is a biobank marketplace that allows researchers to query and license samples through a biobank network. Patients can track the usage of their samples, learn from new insights generated from the samples, and earn money when these samples are sold.